Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for microbiota restoration therapy in recurrent Clostridium difficile infection (completed; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Microbiota restoration therapy (not specified)

Snippet

Sponsor: Rebiotix Inc. | Conditions: Clostridium Difficile Infection | Phase 2 | Status: COMPLETED | Results posted: 2020-05-11